Calcineurin inhibitors in HLA-identical living related donor kidney transplantation

16Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

BackgroundGiven the nephrotoxicity of calcineurin inhibitors (CNIs), we asked whether their addition improved living related donor (LRD) human leukocyte antigen (HLA) identical kidney transplant recipient outcomes.MethodsWe performed a comprehensive literature review and a single-center study comparing patient survival (PS) and graft survival (GS) of LRD HLA-identical kidney transplants for three different immunosuppression eras: Era 1 (up to 1984): anti-lymphocyte globulin (ALG) induction and maintenance immunosuppression with prednisone and azathioprine (AZA) (n = 114); Era 2a (1984-99): CNI added; evolution from ALG to thymoglobulin; AZA to mycophenolate (n = 262). Era 2b (1999-2011): rapid discontinuation of prednisone (thymoglobulin induction, CNI and mycophenolate) in recipients having first or second transplant and not previously on prednisone (n = 77).ResultsDemographics differed by era: recipient (P < 0.0001) and donor age (P < 0.0001) increased and the proportion of Caucasian donors (P = 0.02) and recipients (P = 0.003) decreased with each advancing era. There was no significant difference in PS (P = 0.6); cause of death (P = 0.5); death-censored GS (P = 0.8) or graft loss from acute rejection by era. Graft loss from chronic allograft nephropathy (P = 0.02) and hypertension (P = 0.005) were greater in the CNI eras. There were no significant differences in the 1/creatinine slopes between eras for the first (P = 0.6), second (P = 0.9) or >2 years post-transplant (P = 0.4). Literature review revealed no clear benefits for CNI in these human leukocyte antigen (HLA) identical LRD graft recipients.ConclusionsThis study confirmed that there are no benefits of CNIs for HLA-identical LRD recipients. Moreover, we did find evidence of potential harm. Thus, monotherapy or early discontinuation of CNI should be given consideration in these patients. © 2013 The Author.

References Powered by Scopus

Chronic renal failure after transplantation of a nonrenal organ

1944Citations
N/AReaders
Get full text

The Natural History of Chronic Allograft Nephropathy

1761Citations
N/AReaders
Get full text

Identifying specific causes of kidney allograft loss

690Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Assessment and management of hypertension in transplant patients

141Citations
N/AReaders
Get full text

Pediatric kidney transplantation: A historical review

83Citations
N/AReaders
Get full text

The safety of calcineurin inhibitors for kidney-transplant patients

68Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Verghese, P. S., Dunn, T. B., Chinnakotla, S., Gillingham, K. J., Matas, A. J., & Mauer, M. S. (2014). Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. Nephrology Dialysis Transplantation, 29(1), 209–218. https://doi.org/10.1093/ndt/gft447

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

67%

Professor / Associate Prof. 4

19%

Researcher 3

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

70%

Agricultural and Biological Sciences 3

13%

Computer Science 2

9%

Social Sciences 2

9%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free